Making the case for advance provision of mifepristone and misoprostol for abortion in the United States | BMJ Sexual & Reproductive Health

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via FSRH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via FSRH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Editorial

Making the case for advance provision of mifepristone and misoprostol for abortion in the United States

Online download statistics by month:

Online download statistics by month: December 2021 to October 2023

	Abstract	Full	Pdf
Dec 2021	3442	49	27
Jan 2022	714	139	22
Feb 2022	329	10	6
Mar 2022	250	12	13
Apr 2022	329	7	6
May 2022	474	1	0
Jun 2022	776	41	5
Jul 2022	530	28	6
Aug 2022	233	14	5
Sep 2022	454	18	1
Oct 2022	975	29	10
Nov 2022	1264	26	7
Dec 2022	2206	11	0
Jan 2023	1509	11	3
Feb 2023	311	11	13
Mar 2023	197	11	4
Apr 2023	265	9	5
May 2023	251	5	3
Jun 2023	185	6	3
Jul 2023	114	6	1
Aug 2023	147	4	1
Sep 2023	147	2	2
Oct 2023	152	9	1
Total	15254	459	144